CN Stock MarketDetailed Quotes

688266 Suzhou Zelgen Biopharmaceuticals

Watchlist
  • 67.59
  • +0.67+1.00%
Market Closed Dec 13 15:00 CST
17.89BMarket Cap-102.56P/E (TTM)

Suzhou Zelgen Biopharmaceuticals Key Stats

Suzhou Zelgen Biopharmaceuticals Q3 2024 Earnings Date

Currency:CNYOct 26, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
--
143.42M
--
+130.67%
EPS
--
-0.12
--
--
Strong Buy

Dec 14, 2024

Suzhou Zelgen Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.189B--
--2024/FY-- / 614.565M--
--2023/FY386.439M / 429.000M--
--2021/FY190.361M / 208.000M--
--2020/FY27.661M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.189B--
--2024/FY-- / 614.565M--
--2023/FY386.439M / 429.000M--
--2021/FY190.361M / 208.000M--
--2020/FY27.661M / 0.000--

Unlock Free Earnings Estimates

Suzhou Zelgen Biopharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Dec 14, 2024

Strong Buy

  • Strong Buy

    86.67%
  • Buy

    13.33%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data